Email this article Optimization of M2e cassette amino acid composition for the development of universal influenza vaccine
- Authors: Mezhenskaya D.А.1, Isakova-Sivak I.N.1, Katelnikova A.E.2, Rudenko L.G.1
-
Affiliations:
- Institute of Experimental Medicine
- Institure of Preclinical Research
- Issue: Vol 21, No 3 (2021)
- Pages: 127-130
- Section: Conference proceedings
- URL: https://bakhtiniada.ru/MAJ/article/view/76326
- DOI: https://doi.org/10.17816/MAJ76326
- ID: 76326
Cite item
Open Access
Access granted
Subscription Access
Abstract
The development of a universal influenza vaccine with a wide spectrum and duration of action is one of the serious public health problems. This study is dedicated to optimization of an immunogen covering the M2e epitopes of influenza A viruses circulating in the natural reservoir, as well as the creation of a prototype of a universal influenza vaccine with subsequent quantitative and qualitative assessment of the induced anti-M2e responses in ferrets.
Full Text
##article.viewOnOriginalSite##About the authors
Daria А. Mezhenskaya
Institute of Experimental Medicine
Author for correspondence.
Email: dasmez@iemspb.ru
ORCID iD: 0000-0001-6922-7682
SPIN-code: 5799-8802
Junior Reseacher of Laboratory of Immunology and Prevention of Viral Infections, A.A. Smorodintsev Department of Virology
Russian Federation, Saint PetersburgIrina N. Isakova-Sivak
Institute of Experimental Medicine
Email: isakova.sivak@gmail.com
ORCID iD: 0000-0002-2801-1508
SPIN-code: 3469-3600
Dr. Sci. (Biol.), Head of Laboratory of Immunology and Prevention of Viral Infections, A.A. Smorodintsev Department of Virology
Russian Federation, Saint PetersburgAnastasiya E. Katelnikova
Institure of Preclinical Research
Email: katelnikova.ae@doclinika.ru
ORCID iD: 0000-0003-3203-9869
SPIN-code: 7473-6070
PhD
Russian Federation, Leningrad Region, KuzmolovskyLarisa G. Rudenko
Institute of Experimental Medicine
Email: vaccine@mail.ru
ORCID iD: 0000-0002-0107-9959
SPIN-code: 4181-1372
Dr. Sci. (Med.), Professor, Head of the A.A. Smorodintsev Department of Virology
Russian Federation, Saint PetersburgReferences
- Deng L, Cho KJ, Fiers W, Saelens X. M2e-based universal influenza a vaccines. Vaccines (Basel). 2015;3(1):105–136. doi: 10.3390/vaccines3010105
- FuruseY, Suzuki A, Kamigaki T, Oshitani H. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J. 2009;(6):67. doi: 10.1186/1743-422X-6-67
- Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi ATJ. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol. 2002;83(Pt 8):1851–1859. doi: 10.1099/0022-1317-83-8-1851
- Liu W, Zou P, Chen YH. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunol Lett. 2004;93(2–3):131–136. doi: 10.1016/j.imlet.2004.03.003
- Zebedee SL, Lamb RA. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol. 1988;62(8):2762–2772. doi: 10.1128/JVI.62.8.2762-2772.1988
Supplementary files
